CLPT Stock Up 93% after 6-Day Win Streak
ClearPoint Neuro (CLPT) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 93% return. The company has gained about $564 Mil in value over the last 6 days, with its current market capitalization at about $610 Mil. The stock remains 40.2% above its value at the end of 2024. This compares with year-to-date returns of 13.3% for the S&P 500.
CLPT provides platforms for minimally invasive brain surgeries using real-time MRI guidance, enabling precise insertion of electrodes, biopsy needles, pharmaceuticals, and laser catheters.
Comparing CLPT Stock Returns With The S&P 500
The following table summarizes the return for CLPT stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CLPT | S&P 500 |
|---|---|---|
| 1D | 0.1% | 0.3% |
| 6D (Current Streak) | 92.6% | -0.0% |
| 1M (21D) | 105.6% | 2.5% |
| 3M (63D) | 80.7% | 7.4% |
| YTD 2025 | 40.2% | 13.3% |
| 2024 | 126.5% | 23.3% |
| 2023 | -19.8% | 24.2% |
| 2022 | -24.5% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 63 S&P constituents with 3 days or more of consecutive gains and 21 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 39 | 10 |
| 4D | 7 | 2 |
| 5D | 11 | 5 |
| 6D | 2 | 0 |
| 7D or more | 4 | 4 |
| Total >=3 D | 63 | 21 |
Key Financials for ClearPoint Neuro (CLPT)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $24.0 Mil | $31.4 Mil |
| Operating Income | $-22.4 Mil | $-19.7 Mil |
| Net Income | $-22.1 Mil | $-18.9 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $8.5 Mil | $9.2 Mil |
| Operating Income | $-6.2 Mil | $-5.7 Mil |
| Net Income | $-6.0 Mil | $-5.8 Mil |
While CLPT stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.